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Abstract 
 
Background: Inherited bleeding disorders in females 
are under-diagnosed, eventually leading to multiple 
problems. This situation is further worsened by the 
inadequate information , non – availability of diagnostic 
facilities and low awareness on the clinical side  
Methods: In this non – interventional descriptive study 
, females with inherited bleeding disorders were assessed. 
Clinical presentations, demographic data and management 
received was recorded. Complete blood counts, 
prothrombin time, activated partial thromboplastin time, 
thrombin time and platelet function studies were 
performed, where required.. 
Results: In all the patients with inherited bleeding 
disorders , females constituted 16.85%. von Willebrand 
disease was  the commonest (50.84%) out of all inherited 
bleeding disorders in females. In rest of the females 
autosomal recessive coagulation defects and platelet 
function defects constituted 25.42% and 23.72%, 
respectively.  Majority of the females (83.04%) were below 
17 years of age. Menorrhagia (46.87%) was the commonest 
clinical episode. Spontaneous bleed was seen in 95% 
episodes. Majority of the episodes (94.14%) were soft 
tissue bleeding episodes and joint bleeds were minimal 
(5.68%). Tranexamic acid was the most commonly used 
therapeutic agent . Surgical intervention was employed in 
18 episodes.  
Conclusion: Females with inherited bleeding disorders 
 have severely impaired quality of life , fail to get proper 
management and go through unwanted surgeries ( D&C; 
Hysterectomies).     
 
Introduction 
 
Very little information is available regarding 
gynaecological and obstetric problems in females with 
inherited bleeding disorders 1 Estimates suggest that 
10 to 20% of women with menorrhagia have an 
underlying inherited bleeding disorder2,3. 
Menorrhagia is the most common manifestation seen 
in women with inherited bleeding disorders, but it is 
not the only abnormality.  Females in their child 
bearing years are more likely to manifest an inherited 
bleeding disorder than premenarcheal or 
postmenopausal females. During pregnancy there is 
greater risk of miscarriage and bleeding complications. 
At the time of child birth, women with bleeding 
disorders appear to be more likely to experience 
postpartum haemorrhage, particularly delayed or 
secondary postpartum haemorrhage. Vaginal or 
vulvar haematomas, extremely rare in women without 
bleeding disorder, are not uncommon.  Women with 
bleeding disorders are more likely to undergo a 
hysterectomy and more likely to have this operation at 
a younger age.  Most of the times hysterectomies in 
these patients are performed in ignorance, rather than 
an option.  These women appear to be at an increased 
risk of developing haemorrhagic ovarian cysts and 
possibly endometriosis. As they grow older, they may 
be more likely to manifest conditions, which present 
with bleeding such as fibroids, endometrial 
hyperplasia and polyps. While women with bleeding 
disorders are at risk for the same obstetrical and 
gynaecological problems that affect all women, they 
appear to be disproportionately affected by conditions 
that manifest with bleeding.4 With this background, an 
overview of common inherited bleeding disorders, in 
females, focusing on their clinical manifestations, 
complications, diagnosis, treatment options and 
hindrances in their management can be considered as 
a likely objective to explore.  
 
Patients and Methods 
         
In this non – interventional descriptive study, 
females with inherited bleeding disorders presenting 
to Haemophilia Patients Welfare Society, 
Rawalpindi/Islamabad chapter and District Head 
Quarters Hospital Rawalpindi were analyzed. 
Demographic data, presenting episodes, diagnostic 
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evaluation and treatment received were recorded 
.Diagnosis was established on the basis of 
Prothrombin Time (PT), Activated Partial 
Thromboplastin Time (APTT) , Thrombin Time (TT), 
Bleeding Time (BT),  Clotting Time (CT), factor level 
estimation ,platelet count , platelet aggregation studies 
 and  examination of peripheral smear. Mixing studies 
were performed by using aged serum (24 hours old 
serum kept   at 37 0 C) and adsorbed plasma (normal 
plasma adsorbed by barium sulphate). Factor levels 
were estimated by using commercially available 
deficient plasmas. Platelet aggregation studies were 
performed by collecting 10 ml of blood in sodium  
citrate. Platelet rich plasma (PRP)  was prepared  by 
centrifuging  the samples at 250 xg and 1500 xg 
respectively for ten minutes. The aggregation pattern  
was studied against different agonists ( ADP,   
Epinephrine, Ristocetin, Collagen)  
 
Results 
 
Von Willebrand disease was the commonest 
,followed by Glanzmann’s thrombasthenia (Table1). 
Age group from 6 to 15 years constituted the  main 
patient’s group (Table 2) Menorrhagia was the most 
frequent presentation (46.87%) . Majority of the 
episodes were soft tissue bleeds. Joint bleeds were 
seen in 6.8% episodes. One patient died because of 
post partum bleed.(Table 3). Three patients presented 
with an acute abdomen due to haemorrhagic ovarian 
cyst. 
 
Table 1: Distribution of  females  with  
inherited bleeding disorders 
Total number of patients with inherited bleeding disorders 
= 350 
Female patients with inherited bleeding disorders = 
59/350( 16.85%) 
Disease Number of Patients(%) 
von Willebrand Disease   30/59 (50.84%) 
Glanzman’s Thrombasthenia   9/59 ( 15.25%) 
Factor V  Deficiency   7/59 (11.86%) 
Factor X Deficiency    4/59 ( 6.77%) 
Factor XIII Deficiency   3/59 ( 5.08%) 
Bernard Soulier Syndrome   5/59 ( 8.47%) 
Factor XI Deficiency  1/59 ( 1.69%) 
 
Table 2: Inherited bleeding disorders in 
females: Age distribution  
Age Number of patients (%) 
Less than 5 years   10/59 ( 16.94%) 
6 – 15 years   39/ 59 (66.10%) 
16 – 25 years   5 / 59 (8.47%) 
 26 – 35 years   2  / 59 ( 3.38%) 
36 – 45 years   2  / 59 (3.38%) 
46 – 55 years  1  / 59 ( 1.69%)  
 
Table 3: Inherited bleeding disorders in  
females: Bleeding episodes 
Menorrhagia      165/352 ( 46.87%) 
Epistaxis      61/352 ( 17.32%) 
Gum bleed      42/352 ( 11.93%) 
Dental  bleed      35/352 (9.94%) 
Bruising       21/352 ( 5.96%) 
Joint bleed      20/352  (5.68%) 
Umbilical cord bleed     4/352 ( 1.13%) 
Haemorrhagic ovarian cysts         4/352 ( 1.13%) 
CNS bleed      2/352 ( 0.56%) 
Postpartum bleed                1/352(0.28%) 
 
Table 4: Platelet agggregation studies  
  von 
Willebrand 
Disease 
Glanzmann’s 
Thrombasthenia 
Bernard 
Soulier 
Syndrome 
Platelet count Normal Normal Decreased 
Platelet size Normal Normal Large 
Aggregation 
with ADP 
Normal Absent Normal 
Aggregation 
with Collagen 
Normal Absent Normal 
Aggregation 
with Ristocetin 
Absent Normal Absent 
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Aggregation 
with 
Epinephrine  
Normal Absent Normal 
 
 
 
      
 
 
 
 
 
 
 
 
 
Fig1 : Platelet aggregation studies in 
females  with inherited bleeding disorders 
 
Table5: Inherited bleeding disorders in 
females: treatment received* 
Treatment   Number of episodes 
Tranexamic Acid      84 / 105 
Fresh Frozen Plasma      40 /  105 
Cryoprecipitate    10 / 105 
Platelet’s concentrates    32 / 105 
Kaote    5  / 105 
DDAVP    21  /105 
Hormonal therapy    39 /105 
Recombinant Factor VII     2 /105 
Dilatation and Curettage    10 / 105 
Laparotomies    5/105  
Hysterectomies   3  /105 
 
In laboratory evaluation prolonged bleeding 
time and APTT and normal PT , along with 
aggregation with all agonists, except Ristocetin , 
established the diagnosis of vWD.  Bernard Soulier 
Syndrome and vWD gave similar results on platelet 
aggregation studies, but in vWD patient’s plasma  plus 
control plasma gave normal  aggregation with 
Ristocetin and in Bernard Soulier Syndrome there was 
thrombocytopenia with giant platelets on peripheral 
smear  (Table 4 ; fig 1). Tranexamic acid was the most 
commonly used therapeutic agent . Surgical 
intervention was employed in 18 episodes (Table 5)  
Discussion  
Despite their high prevalence, these disorders 
often remain undiagnosed, and particularly so unless 
significant iron deficiency anaemia, post operative 
bleeding and/ or transfusion occurs. Failure to 
recognize or even consider a diagnosis of a bleeding 
disorder either by patient or providers, limitation of 
available diagnostic tests ,which are complex  to 
perform and interpret  and the lack of available 
therapeutic agents to treat these disorders are a few of 
the mentionable obstacles 2. 
The commonest inherited bleeding in females 
is von Willebrand Disease (vWD), followed by platelet 
function defects and some autosomal recessive 
coagulation factor deficiencies. Rarely female carriers 
of haemophilia can also have gynaecologic 
complications  1. World wide vWD is considered as the 
 most common  inherited bleeding disorder 5 . Data on 
its epidemiology and impact in developing countries 
are limited.  The biologic  heterogeneity and variable  
presentation  of vWD make diagnosis difficult. 
Although there is no accurate data of the prevalence of 
vWD in developing countries,  available data suggests 
that the proportion of diagnosed cases is lower than 
the expected number, often  accounting for only 6% to 
13% of  patients with hereditary bleeding disorders .  
The number  is expected to be much higher in our set 
up due to high  rate of consanguinity . The prevalence 
of different types of vWD is also  not known which is 
essential for a proper management of these cases  6,7 . 
In an Indian study majority of the patients of vWD 
were type 3 (59.5%), with severe clinical  
manifestations . The high prevalence of type 3 and low 
prevalence of type 1 , which is in contrast to Western 
reports  , can be ascribed to the consanguineous       
marriages , low awareness of the disease and also the 
under diagnosis of mild cases in this part of world  8 . 
The diagnosis of vWD is  difficult because the intensity 
of symptoms is highly variable . At one end are type 3 
patients who present in childhood with severe 
bleeding tendency and seek medical advice earlier and 
 on the other end the patients with milder disease  
have very vague symptoms which they only tell when 
they are specifically asked . In between are the 
majority of patients who have unusual bleeding 
tendency but diagnosis is missed or delayed   
In laboratory diagnosis of these problems time 
of testing in women’s cycle is an important 
confounding factor. Fluctuating estrogen levels can 
Glanzman’s Thrombastheniavon  Willebrand diseaseNormal Control
Restocetine
Restocetine
Patient+Control
     Ristocetine
Restocetine
Epinephrine
Epinephrine
Epinephrine
A.D.P.
A.D.P.
A.D.P.
Collagen Collagen Collagen
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interfere in the estimation . Most of these women 
remain undiagnosed , diagnosed after a long delay or 
go through repeated laboratory evaluations before 
getting a proper  diagnosis. It is recommended that 
blood testing, in these women,  should be done during 
the first four days of menstrual period when  their 
factor levels are lowest 9 .     
With the exception of Haemophilia A and B , 
deficiencies of all the other plasma clotting proteins 
such as afibrinogenemia, hypofibrinogenemia, 
deficiencies of factor V and combined factor V and VIII 
, VII, X, XI, and XIII are inherited in an autosomal, 
mostly recessive, manner. Due to rarity of these 
deficiencies  , which are expressed clinically only in 
homozygous or compound heterozygous , the type 
and severity of  symptoms , the underlying molecular 
defects and the actual management of bleeding 
episodes are not well established as for haemophilia . 
In countries where consanguineous marriages are 
frequent  recessive inherited coagulation deficiencies 
are more frequent. All these are associated with 
menorrhagia , recurrent abortions, haemorrhagic 
ovarian cysts , post partum haemorrhage and many 
other complications related with female reproductive 
system 10 .   
As many as 10 to 20% of women with 
menorrhagia have an underlying   bleeding disorder 
and in females with inherited bleeding disorders it is 
the commonest manifestation (table 3) 11. 
Approximately 80% of women with inherited bleeding 
disorders suffer from menorrhagia . Menorrhagia in 
females with inherited bleeding disorders typically 
present at menarche , in  contrast  to other causes of  
menorrhagia 12 . In our data majority of patients were 
under 18 years of age (table 2) .It leads to under 
representation of menorrhagia in our data as 
compared to international   data. Then in  this part of 
the world majority  of the cases of vWD are of type 3, 
with severe bleeding manifestations , while world 
wide type –1 is the commonest . It reflects under 
diagnosis  of cases of vWD with mild menorrhagia . 
But it must be appreciated that over the time this 
percentage will increase, reflecting an upcoming 
disease load 5 .   
In the present series the cases of haemorrhagic 
ovarian cysts underwent laparotomies. Surgeries in 
these cases might have been prevented if they had 
been diagnosed earlier and therapeutic/conservative 
management considered 13. These cysts are due to 
excessive bleeding into the corpus luteum at the time 
of ovulation. Rupture of these cysts may result in 
haemoperitonium and secondary increased 
production of fibrin in the peritoneal cavity can be a 
major cause of increased formation of pelvic 
adhesions, external occlusion of the fallopian tubes, 
and destruction of the ovarian tissue. It can lead to 
reduced fertility in these patients  14,15 .    
Post partum haemorrhage(PPH) is a 
catastrophic emergency in  these females 16 .In present 
series one female with Glanzmann’s thrombasthenia 
succumbed fatally to this complication . Women with 
risk factors for post partum haemorrhage can be 
identified in antenatal period. Pregnancy usually 
causes a rise in all of the plasma clotting factors except 
factor IX. So, often there is no bleeding problem 
during pregnancy . However following child birth, 
factor levels may fall rapidly and lead to post partum 
bleeding. Every labour suite should have appropriate 
PPH protocols, A multidisciplinary approach 
involving senior obstetrician, intensive care, 
haematologist and blood bank services are the corner 
stone in the management of PPH  17 . 
Pregnancy in this group of women has been 
found to be associated with bleeding in early 
pregnancy , repeated miscarriages , abruption placenta 
, intrauterine demise and increased incidence of both 
primary and secondary postpartum haemorrhage .It is 
difficult  to describe pregnancy and labour 
complications in individual manner 18 .  
Many women with inherited bleeding 
disorders are on birth control pills or other hormonal 
therapies .This affects a women’s ability to conceive. 
The long term impact of such prolonged hormonal 
therapy on conception is unknown. Some women with 
inherited bleeding disorders report excessive bleeding 
with intercourse , which may also cause difficulty in 
conception . The impact of inherited bleeding 
disorders on the implantation of fertilized embryo, 
into uterus, is not fully understood 1 .   
Different treatment modalities are used in 
these females , depending upon the type of lesion and 
the nature of episode. Commonly employed agents are 
 oral contraceptive pills(OCP), Tranexamic acid, 
desmopressin , and factor replacement.  Desmopressin 
is contraindicated in vWD type 2b. and not useful in 
type 3. OCP are recommended as the first line 
treatment , especially in adolescent menorrhagia , and 
have been found to effective in majority of  women 19  . 
Tranexamic acid is the most frequently used 
therapeutic agent in different bleeding episodes (Table 
5) in a dose of 1 gm every six hour, for 3 – 4 days, 
during menstruation. It has been found effective in 
54% of cases , when given over 2-3 menstrual cycles 18 . 
Commonly, non steroidal anti inflammatory medicines 
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are prescribed for control of menorrhagia , but their 
use in inherited bleeding disorders is usually  
contraindicated . Recently Recombinant factor VII (rF 
VII a)  was launched, as a universal haemostatic agent, 
for  varied  haemorrhagic manifestations. The rFVIIa 
acts via  tissue factor pathway. Limitations to its use 
are its short half life (2 hours) and high cost. It is  
contraindicated in disseminated intravascular 
coagulation 20  . 
 
Conclusions 
 
1. Bleeding manifestations severely affect 
quality of life of the women with inherited bleeding 
disorders, leading to a limitation in the performance of 
day to day chores, change in career, loss of faith on 
medical profession after being told for years their 
problems are not real, constant fatigue due to iron 
deficiency, painful menstruation or coitus, feeling of 
embarrassment, undue endometrial biopsies and 
hysterectomies. A proper management approach is 
usually rewarded with an overall change in the 
patient’s personality. 
2. Failure to investigate the women with 
inherited bleeding disorders limit the potential 
benefits of different therapies like, desmopressin 
(DDAVP), tranexamic acid, FFP and cryoprecipitate  
3. The milder forms or carrier states of these 
disorders may remain asymptomatic. So, the diagnosis 
of inherited bleeding disorder in a female should 
provide clear prognostic and therapeutic indications 
that are distinct from the burdens associated with an 
unjustified genetic disease stigma, anxiety that may be 
caused by overestimates of a patient’s bleeding risk 
and inappropriate resource expenditures. Therefore, at 
least for the mild from, it remains unclear whether the 
benefits of a diagnosis outweigh its disadvantages.   
4. There is inadequate information, non- 
availability of diagnostic and management facilities 
and low level of awareness on the clinical side, about 
inherited bleeding disorders in females. Hence it is 
required to raise understanding about the intricacies of 
these disorders. 
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